Keith S. Manchester - 28 Sep 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
/s/ Keith Manchester
Issuer symbol
ROIV
Transactions as of
28 Sep 2023
Net transactions value
-$79,650,463
Form type
4
Filing time
02 Oct 2023, 21:05:20 UTC
Previous filing
14 Sep 2023
Next filing
07 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Sale $26,400,794 -2,285,783 -8.2% $11.55 25,724,561 28 Sep 2023 Held by QVT Deferred Compensation Holdings Ltd F1
transaction ROIV Common Shares Sale $35,335,700 -3,059,368 -8.2% $11.55 34,430,591 28 Sep 2023 Held by QVT Financial Investment Cayman Ltd. F1
transaction ROIV Common Shares Sale $12,758,118 -1,104,599 -8.2% $11.55 12,431,330 28 Sep 2023 Held by QVT Roiv Hldgs Onshore Ltd F1
transaction ROIV Common Shares Sale $5,155,851 -446,394 -8.2% $11.55 5,023,787 28 Sep 2023 Held by QVT P&E Roiv Hldgs Ltd. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.